AFIB Stock Overview
Designs, manufactures, and markets various tools for catheter-based ablation procedures to treat various arrhythmias in the United States and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
Community vs My Fair Value
Create NarrativeSelect a narrative for quick price alerts from the community, or create your own.
My Notes
Capture your thoughts, links and company narrative
Acutus Medical, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$0.042 |
| 52 Week High | US$0.27 |
| 52 Week Low | US$0.025 |
| Beta | -0.13 |
| 1 Month Change | -28.81% |
| 3 Month Change | -35.38% |
| 1 Year Change | -76.55% |
| 3 Year Change | -97.45% |
| 5 Year Change | n/a |
| Change since IPO | -99.84% |
Recent News & Updates
Recent updates
Investors Give Acutus Medical, Inc. (NASDAQ:AFIB) Shares A 29% Hiding
Feb 24
Market Cool On Acutus Medical, Inc.'s (NASDAQ:AFIB) Revenues Pushing Shares 43% Lower
Dec 20Take Care Before Diving Into The Deep End On Acutus Medical, Inc. (NASDAQ:AFIB)
Jul 18Acutus files for FDA approval of catheter ablation system AcQBlate
Oct 18Acutus Medical Non-GAAP EPS of -$0.93 misses by $0.17, revenue of $4.1M beats by $0.13M
Aug 11Acutus Medical sees Q2 revenue above consensus estimate
Jul 21Acutus Medical, Inc. (NASDAQ:AFIB) Analysts Just Trimmed Their Revenue Forecasts By 25%
Apr 06Acutus Medical: A Name To Slowly Accumulate
Sep 04Acutus Medical, Inc.: Paradigm-Shifting Technology At A Shocking Price
Jul 21Acutus Medical cleared to start atrial fibrillation IDE trial
May 27Analysts Have Been Trimming Their Acutus Medical, Inc. (NASDAQ:AFIB) Price Target After Its Latest Report
May 15Shareholder Returns
| AFIB | US Medical Equipment | US Market | |
|---|---|---|---|
| 7D | -6.7% | -3.2% | -1.7% |
| 1Y | -76.5% | 6.4% | 12.1% |
Return vs Industry: AFIB underperformed the US Medical Equipment industry which returned 6.4% over the past year.
Return vs Market: AFIB underperformed the US Market which returned 12.1% over the past year.
Price Volatility
| AFIB volatility | |
|---|---|
| AFIB Average Weekly Movement | 26.8% |
| Medical Equipment Industry Average Movement | 8.3% |
| Market Average Movement | 6.3% |
| 10% most volatile stocks in US Market | 17.2% |
| 10% least volatile stocks in US Market | 3.3% |
Stable Share Price: AFIB's share price has been volatile over the past 3 months compared to the US market.
Volatility Over Time: AFIB's weekly volatility (27%) has been stable over the past year, but is still higher than 75% of US stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2011 | 232 | Takeo Mukai | www.acutusmedical.com |
Acutus Medical, Inc. designs, manufactures, and markets various tools for catheter-based ablation procedures to treat various arrhythmias in the United States and internationally. Its product portfolio includes novel access sheaths, transseptal crossing tools, diagnostic and mapping catheters, conventional and contact ablation catheters, and mapping and imaging consoles and accessories, as well as supporting algorithms and software programs. Acutus Medical, Inc. was incorporated in 2011 and is headquartered in Carlsbad, California.
Acutus Medical, Inc. Fundamentals Summary
| AFIB fundamental statistics | |
|---|---|
| Market cap | US$1.61m |
| Earnings (TTM) | -US$5.27m |
| Revenue (TTM) | US$15.38m |
0.1x
P/S Ratio-0.2x
P/E RatioIs AFIB overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| AFIB income statement (TTM) | |
|---|---|
| Revenue | US$15.38m |
| Cost of Revenue | US$15.49m |
| Gross Profit | -US$110.00k |
| Other Expenses | US$5.16m |
| Earnings | -US$5.27m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.18 |
| Gross Margin | -0.72% |
| Net Profit Margin | -34.26% |
| Debt/Equity Ratio | -314.1% |
How did AFIB perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/03/10 23:58 |
| End of Day Share Price | 2025/03/10 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Acutus Medical, Inc. is covered by 7 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Robert Hopkins | BofA Global Research |
| Michael Gorman | BTIG |
| William Plovanic | Canaccord Genuity |